The progress and current status of immunotherapy in acute myeloid leukemia Dan YangXiuqun ZhangYanli Xu Review Article 28 October 2017 Pages: 1965 - 1982
The role of mutant IDH1 and IDH2 inhibitors in the treatment of acute myeloid leukemia Samah NassereddineCoen J. LapImad Tabbara Review Article 31 October 2017 Pages: 1983 - 1991
Epidemiological, genetic, and clinical characterization by age of newly diagnosed acute myeloid leukemia based on an academic population-based registry study (AMLSG BiO) Gabriele NagelD. WeberGerman-Austrian AML Study Group (AMLSG) Original Article Open access 31 October 2017 Pages: 1993 - 2003
Causes and prognostic factors for early death in patients with acute promyelocytic leukemia treated with single-agent arsenic trioxide Jinxiao HouShuye WangXiaoxia Li Original Article 22 September 2017 Pages: 2005 - 2013
The prognostic significance of serum XCL1 concentration in patients with acute lymphoblastic leukemia: a pilot study Cesar Homero Gutiérrez-AguirreJuan Antonio Flores-JiménezDavid Gómez-Almaguer Original Article 13 October 2017 Pages: 2015 - 2024
A predictive model of response to erythropoietin stimulating agents in myelodysplastic syndrome: from the Canadian MDS patient registry Brett L. HoustonJennifer JayakarRena Buckstein Original Article 03 October 2017 Pages: 2025 - 2029
Horse versus rabbit antithymocyte globulin in immunosuppressive therapy of treatment-naïve aplastic anemia: a systematic review and meta-analysis Nan YangJinqiu ChenWanggang Zhang Original Article 30 September 2017 Pages: 2031 - 2043
Effect of thrombopoietin receptor agonists on leukocyte and haematopoietic stem and progenitor cells in the peripheral blood of patients with immune thrombocytopenic purpura Gürkan BalDepré FabianAbdulgabar Salama Original Article 30 September 2017 Pages: 2045 - 2056
Efficacy and prognosis of antiviral therapy on hepatitis C following treatment of lymphoma in HCV-positive diffuse large-cell lymphoma Yutaka TsutsumiChie NakayamaTakanori Teshima Original Article Open access 22 September 2017 Pages: 2057 - 2061
Clinicopathological features of primary splenic follicular lymphoma Joji ShimonoHiroaki MiyoshiKoichi Ohshima Original Article 03 October 2017 Pages: 2063 - 2070
Novel agent-based salvage autologous stem cell transplantation for relapsed multiple myeloma Beatrice Anna ZannettiPaola TacchettiElena Zamagni Original Article 24 October 2017 Pages: 2071 - 2078
High level of soluble interleukin-2 receptor in serum predicts treatment resistance and poor progression-free survival in multiple myeloma Liang WangJing-hua WangZhong-jun Xia Original Article 05 September 2017 Pages: 2079 - 2088
At least partial hematological response after first cycle of treatment predicts organ response and long-term survival for patients with AL amyloidosis receiving bortezomib-based treatment Kai-ni ShenJun FengJian Li Original Article 27 September 2017 Pages: 2089 - 2094
Diagnostic value of sTREM-1, IL-8, PCT, and CRP in febrile neutropenia after autologous stem cell transplantation C. S. MichelD. TeschnerMarkus P. Radsak Original Article 17 September 2017 Pages: 2095 - 2101
VEGF, ANGPT1, ANGPT2, and MMP-9 expression in the autologous hematopoietic stem cell transplantation and its impact on the time to engraftment Mateusz NowickiAgnieszka WierzbowskaAnna Szmigielska-Kapłon Original Article 27 September 2017 Pages: 2103 - 2112
Clinical features of hematological disorders with increased large granular lymphocytes (LGLs): a retrospective study Kensuke MatsudaKazuki TaokaMineo Kurokawa Letter to the Editor 02 November 2017 Pages: 2113 - 2115
Interleukin-6 in idiopathic multicentric Castleman’s disease after long-term tocilizumab Mitsuhiro AkiyamaHidekata YasuokaTsutomu Takeuchi Letter to the Editor 01 September 2017 Pages: 2117 - 2119
Leonine facies due to Sezary syndrome: complete clinical, radiologic, and molecular remission with alemtuzumab Bonnie KhoHoward H. N. WongYok-Lam Kwong Letter to the Editor 21 August 2017 Pages: 2121 - 2123
Relapsed subcutaneous panniculitis-like T cell lymphoma: role of haploidentical hematopoietic stem cell transplant Bhagirathbhai DholariaRaj J. PatelVivek Roy Letter to the Editor 06 September 2017 Pages: 2125 - 2126
Therapy-related acute myeloid leukemia with inv(16) after successful therapy for de novo acute myeloid leukemia with t(8;21) Haigang ShaoQian YangJinlan Pan Letter to the Editor 24 August 2017 Pages: 2127 - 2129
Rare gene variants in a patient with azathioprine-induced lethal myelosuppression Xiaoxue YangHeng XuLi Yang Letter to the Editor Open access 22 August 2017 Pages: 2131 - 2133
Congenital dyserythropoietic anemia type II mimicking hereditary spherocytosis in Indian patient with SEC23B-Y462C mutations Prabhakar KedarVaishali ParmarManisha Madkaikar Letter to the Editor 07 September 2017 Pages: 2135 - 2139
Cytogenetic evidence for the clonal hematopoietic cell origin of alveolar macrophages in myelodysplastic syndrome-associated pulmonary alveolar proteinosis Yuya NagaiChiyuki KishimoriHitoshi Ohno Letter to the Editor 28 August 2017 Pages: 2141 - 2143